Innovation Pharmaceuticals Inc (IPIX)

[wsbc]

Who is this, and what's she doing here?


On September 1, 2018, the Company also issued to Ms. Anne Ponugoti, Associate Director, Clinical Sciences of the Company, 5,000 shares of the Company’s common stock and 5,000 options to purchase common stock with same vesting periods as the common stock and options issued to Ms. Ponugoti. The total value of the 5,000 shares and 5,000 options were approximately $2,000 each, based on the closing bid price as quoted on the OTC on August 31, 2018 at $0.40 per share. During the three months and nine months ended March 31, 2019, the stock-based compensation expense was not significant. She left the Company on January 15, 2019.

(apologies... just noticed that BooDog had posted elsewhere that she'd signed-on in 2017. First time I've noticed her mentioned in a 10-Q in the last several years)